Hu W, Wang W, Liao H, Bulloch G, Zhang X, Shang X
NPJ Parkinsons Dis. 2024; 10(1):130.
PMID: 38982064
PMC: 11233508.
DOI: 10.1038/s41531-024-00713-2.
Licitra R, Marchese M, Naef V, Ogi A, Martinelli M, Kiferle C
Biomedicines. 2022; 10(8).
PMID: 36009367
PMC: 9404760.
DOI: 10.3390/biomedicines10081820.
Paes-Colli Y, Aguiar A, Isaac A, Ferreira B, Campos R, Pinheiro Trindade P
Front Cell Neurosci. 2022; 16:917164.
PMID: 35707521
PMC: 9189313.
DOI: 10.3389/fncel.2022.917164.
Wang M, Liu H, Ma Z
Front Cell Neurosci. 2022; 16:832854.
PMID: 35264932
PMC: 8900732.
DOI: 10.3389/fncel.2022.832854.
Jing X, Yuan X, Luo X, Zhang S, Wang X
Curr Neuropharmacol. 2022; 21(8):1806-1826.
PMID: 35193486
PMC: 10514518.
DOI: 10.2174/1570159X20666220222150811.
Quality of Life and a Surveillant Endocannabinoid System.
de Melo Reis R, Isaac A, Freitas H, Almeida M, Schuck P, Ferreira G
Front Neurosci. 2021; 15:747229.
PMID: 34776851
PMC: 8581450.
DOI: 10.3389/fnins.2021.747229.
Medium-throughput zebrafish optogenetic platform identifies deficits in subsequent neural activity following brief early exposure to cannabidiol and Δ-tetrahydrocannabinol.
Kanyo R, Amin M, Locskai L, Bouvier D, Olthuis A, Allison W
Sci Rep. 2021; 11(1):11515.
PMID: 34075141
PMC: 8169761.
DOI: 10.1038/s41598-021-90902-3.
Cannabis for Restless Legs Syndrome.
Ghorayeb I
Adv Exp Med Biol. 2021; 1297:173-181.
PMID: 33537945
DOI: 10.1007/978-3-030-61663-2_13.
Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders.
Estrada J, Contreras I
Curr Neuropharmacol. 2020; 18(8):769-787.
PMID: 32065105
PMC: 7536826.
DOI: 10.2174/1570159X18666200217140255.
Early Exposure to THC Alters M-Cell Development in Zebrafish Embryos.
Amin M, Ahmed K, Ali D
Biomedicines. 2020; 8(1).
PMID: 31947970
PMC: 7168183.
DOI: 10.3390/biomedicines8010005.
More evidence of cannabis efficacy in restless legs syndrome.
Ghorayeb I
Sleep Breath. 2019; 24(1):277-279.
PMID: 31820197
DOI: 10.1007/s11325-019-01978-1.
Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and L-DOPA-Induced Dyskinesia.
Ferreira Junior N, Dos-Santos-Pereira M, Guimaraes F, Del Bel E
Neurotox Res. 2019; 37(1):12-29.
PMID: 31637586
DOI: 10.1007/s12640-019-00109-8.
Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology.
Rodrigues R, Lourenco D, Paulo S, Mateus J, Ferreira M, Mouro F
Molecules. 2019; 24(7).
PMID: 30959794
PMC: 6480122.
DOI: 10.3390/molecules24071350.
Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical Determination.
Goncalves J, Rosado T, Soares S, Simao A, Caramelo D, Luis A
Medicines (Basel). 2019; 6(1).
PMID: 30813390
PMC: 6473697.
DOI: 10.3390/medicines6010031.
Medicinal Cannabis for Parkinson's Disease: Practices, Beliefs, and Attitudes Among Providers at National Parkinson Foundation Centers of Excellence.
Bega D, Simuni T, Okun M, Chen X, Schmidt P
Mov Disord Clin Pract. 2019; 4(1):90-95.
PMID: 30713951
PMC: 6353502.
DOI: 10.1002/mdc3.12359.
Motor neuron development in zebrafish is altered by brief (5-hr) exposures to THC (∆-tetrahydrocannabinol) or CBD (cannabidiol) during gastrulation.
Ahmed K, Amin M, Shah P, Ali D
Sci Rep. 2018; 8(1):10518.
PMID: 30002406
PMC: 6043604.
DOI: 10.1038/s41598-018-28689-z.
The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease.
Barrie N, Manolios N
Eur J Rheumatol. 2017; 4(3):210-218.
PMID: 29164003
PMC: 5685274.
DOI: 10.5152/eurjrheum.2017.17025.
Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.
Babayeva M, Assefa H, Basu P, Chumki S, Loewy Z
Parkinsons Dis. 2017; 2016:1279042.
PMID: 28050308
PMC: 5165161.
DOI: 10.1155/2016/1279042.
Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics.
Koppel B
Neurotherapeutics. 2015; 12(4):788-92.
PMID: 26271953
PMC: 4604174.
DOI: 10.1007/s13311-015-0376-4.
Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection.
More S, Choi D
Mol Neurodegener. 2015; 10:17.
PMID: 25888232
PMC: 4404240.
DOI: 10.1186/s13024-015-0012-0.
